Hardikkumar H. Savsani
Ahmedabad, UP 382210, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats.
Journal: International journal of toxicology
Published: August 30, 2025
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's Blood.
Journal: Drug development research
Published: November 18, 2024
Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammation.
Journal: Inflammopharmacology
Published: September 30, 2024
HIF Stabilizer Desidustat Protects against Complement-Mediated Diseases.
Journal: Drug research
Published: July 11, 2024
Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice.
Journal: International immunopharmacology
Published: July 09, 2024
HIF-PHD inhibitor desidustat ameliorates iron deficiency anemia.
Journal: Toxicology and applied pharmacology
Published: October 16, 2023
Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state.
Journal: Current research in pharmacology and drug discovery
Published: November 16, 2021
Microsomal triglyceride transfer protein inhibitor lomitapide-induced liver toxicity is ameliorated by Triiodothyronine treatment following improved bile homeostasis and β-oxidation.
Journal: Toxicology and applied pharmacology
Published: October 14, 2021
Hepcidin inhibition improves iron homeostasis in ferrous sulfate and LPS treatment model in mice.
Journal: Drug research
Published: July 26, 2021
In vivo antidiabetic activity of nimesulide due to inhibition of amino acid transport.
Journal: Basic & clinical pharmacology & toxicology
Published: June 08, 2021
Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
Journal: European journal of pharmacology
Published: December 22, 2020
Prolyl hydroxylase inhibitor desidustat protects against acute and chronic kidney injury by reducing inflammatory cytokines and oxidative stress.
Journal: Drug development research
Published: December 09, 2020
Last Updated: 09/26/2026